Clinical trial
Intradiscal Injection of an Autologous Alpha-2-macroglobulin (A2M) Concentrate Alleviates Back Pain in FAC-positive Patients
NCT03307876 is registered in ClinicalTrials.gov with Scuderi, Gaetano J., M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intradiscal Injection of an Autologous Alpha-2-macroglobulin (A2M) Concentrate Alleviates Back Pain in FAC-positive Patients
- Lead sponsor
- Scuderi, Gaetano J., M.D.
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- May 31, 2015
- Enrollment
- 24 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.